Mineralocorticoid Receptor Antagonists in Type 2 Diabetes
NCT02809963
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
140
Enrollment
OTHER
Sponsor class
Conditions
Diabetes Type 2
Interventions
DRUG:
Eplerenone
DRUG:
Placebo
Sponsor
Herlev Hospital